Arsenal Medical

Terumo Neuro signed an agreement to acquire Arsenal Medical, a clinical-stage biomaterials company developing NeoCast, an investigational liquid embolic technology for treating chronic subdural hematoma. The acquisition expands Terumo Neuro's neurovascular portfolio.

Arsenal Medical was granted a contract of more than $14 million from the U.S. Army to complete clinical and manufacturing development and regulatory submission for its ResQFoam trauma product.